ArticleProceedings of the National Academy of Sciences of the United States of America2025

Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition.

Joseph L Collura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.